1800 M STREET, NW
SUITE 1000
WASHINGTON,
DC
20036-5807
202.778.1811
202.822.8106 fax
|
Carlos Angulo focuses his practice on food and drug law, including litigation, administrative practice before the Food and Drug Administration (FDA), and legislative policy matters. He has represented generic drug manufacturers and the generic drug trade association in multiple matters before the FDA and in federal trial and appellate courts and has extensive experience in matters arising under the Hatch-Waxman generic drug approval law. He also represents anti-smoking groups, medical device distributors, and other clients in the food and drug field. He also has litigated complex commercial cases, including securities and consumer class actions and antitrust cases. His legislative and policy practice emphasizes civil rights and health-related issues, and he has extensive experience on corporate compliance matters under the Foreign Agents Registration Act and Lobbying Disclosure Act.
Mr. Angulo was an associate at Zuckerman Spaeder LLP from 1999 to 2003 and a partner from 2004 to 2007; he returned to the firm in 2010 after serving as legislative director for Senator Sheldon Whitehouse. Before joining Zuckerman Spaeder, Mr. Angulo served as legislative counsel to Senator Paul Sarbanes and as staff counsel to Senator Paul Simon on the Subcommittee on the Constitution, Senate Judiciary Committee. Before working on Capitol Hill, Mr. Angulo served as a law clerk to the Hon. Phyllis A. Kravitch of the U.S. Court of Appeals for the 11th Circuit, and as a trial attorney in the Civil Division of the Department of Justice.
Experience
-
Successfully defended a generic pharmaceutical company’s right to 180-day exclusivity for a generic version of a blockbuster cholesterol product in litigation brought by a generic competitor in federal district court.
-
Successfully defended a generic pharmaceutical client’s right to FDA approval of a generic version of a popular allergy product against a federal court challenge by the manufacturer of the brand version of the product.
-
Defeated a “citizen petition” seeking the FDA’s ruling that a generic pharmaceutical company forfeited its right to 180-day generic exclusivity.
-
Represents anti-smoking groups in matters before the FDA and in federal courts, with a focus on the 2009 tobacco law.
-
Filed an amicus curiae brief in the U.S. Supreme Court for Rep. Henry Waxman regarding the interpretation of provisions of the Hatch-Waxman law.
-
Counsels the Reagan-Udall Foundation, a 501(c)(3) corporation created by Congress to assist the FDA in its mission.
-
Testified before the U.S. Senate Committee on Health, Education, Labor, and Pensions and the Senate Judiciary Committee on patent and exclusivity provisions of proposed bioterrorism legislation.
EDUCATION
-
Yale Law School,
J.D.,
1989, Finalist, Moot Court Competition; Finalist, Moot Court Brief Writing Competition; Member, Moot Court Board
-
Haverford College,
B.A.,
1986, magna cum laude; Phi Beta Kappa; Chairman, Haverford College Honor Council
COURT ADMISSIONS
- U.S. Supreme Court
- U.S. Court of Appeals, District of Columbia Circuit
- U.S. Court of Appeals, 3rd Circuit
- U.S. Court of Appeals, 11th Circuit
- U.S. District Court, District of Columbia
BAR ADMISSIONS
- District of Columbia
- New York
|
PRACTICES
Related Information
|